Pediatr Gastroenterol Hepatol Nutr.  2016 Sep;19(3):186-192. 10.5223/pghn.2016.19.3.186.

Correlation between Colon Transit Time Test Value and Initial Maintenance Dose of Laxative in Children with Chronic Functional Constipation

• Kim MR
• Park HW
• Son JS
• Lee R
• Bae SH

• KMID: 2364777
• DOI: http://doi.org/10.5223/pghn.2016.19.3.186

Abstract

PURPOSE
To evaluate the correlation between colon transit time (CTT) test value and initial maintenance dose of polyethylene glycol (PEG) 4000 or lactulose.
METHODS
Of 415 children with chronic functional constipation, 190 were enrolled based on exclusion criteria using the CTT test, defecation diary, and clinical chart. The CTT test was performed with prior disimpaction. The laxative dose for maintenance was determined on the basis of the defecation diary and clinical chart. The Shapiro-Wilk test and Pearson's and Spearman's correlations were used for statistical analysis.
RESULTS
The overall group median value and interquartile range of the CTT test was 43.8 (31.8) hours. The average PEG 4000 dose for maintenance in the overall group was 0.68±0.18 g/kg/d; according to age, the dose was 0.73±0.16 g/kg/d (<8 years), 0.53±0.12 g/kg/d (8 to <12 years), and 0.36±0.05 g/kg/d (12 to 15 years). The dose of lactulose was 1.99±0.43 mL/kg/d (<8 years) or 1.26±0.25 mL/kg/d (8 to <12 years). There was no significant correlation between CTT test value and initial dose of laxative, irrespective of the subgroup (encopresis, abnormal CTT test subtype) for either laxative. Even in the largest group (overall, n=109, younger than 8 years and on PEG 4000), the correlation was weak (Pearson's correlation coefficient [R]=0.268, p=0.005). Within the abnormal transit group, subgroup (n=73, younger than 8 years and on PEG 4000) correlation was weak (R=0.267, p=0.022).
CONCLUSION
CTT test value cannot predict the initial maintenance dose of PEG 4000 or lactulose with linear correlation.

Keyword

Intestinal transit; Laxatives; Correlation; Constipation; Child

MeSH Terms

Child*
Colon*
Constipation*
Defecation
Humans
Lactulose
Laxatives
Polyethylene Glycols
Lactulose
Laxatives
Polyethylene Glycols

Reference

1. Loening-Baucke V. Chronic constipation in children. Gastroenterology. 1993; 105:1557–1564.

2. Levine MD. Children with encopresis: a descriptive analysis. Pediatrics. 1975; 56:412–416.

3. Youssef NN, Di Lorenzo C. Childhood constipation: evaluation and treatment. J Clin Gastroenterol. 2001; 33:199–205.

4. van Ginkel R, Reitsma JB, Büller HA, van Wijk MP, Taminiau JA, Benninga MA. Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology. 2003; 125:357–363.

5. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014; 58:258–274.

6. Pashankar DS, Bishop WP, Loening-Baucke V. Long-term efficacy of polyethylene glycol 3350 for the treatment of chronic constipation in children with and without encopresis. Clin Pediatr (Phila). 2003; 42:815–819.

7. Dupont C, Leluyer B, Amar F, Kalach N, Benhamou PH, Mouterde O, et al. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr. 2006; 42:178–185.

8. Lee JH, Lee R, Bae SH. Efficacy and safety of electrolytes-free polyethylene glycol (PEG) 4000 for disimpaction in children with chronic functional constipation. Korean J Pediatr. 2008; 51:391–395.

9. Lee SH, Bae SH. Maintenance dose of electrolyte free polyethylene glycol (PEG) 4000 in Korean children with chronic functional constipation. Korean J Pediatr. 2007; 50:1212–1216.

10. Southwell BR, Clarke MC, Sutcliffe J, Hutson JM. Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int. 2009; 25:559–572.

11. Yoo HY, Kim MR, Park HW, Son JS, Bae SH. Colon transit time test in Korean children with chronic functional constipation. Pediatr Gastroenterol Hepatol Nutr. 2016; 19:38–43.

12. Velde SV, Notebaert A, Meersschaut V, Herregods N, Van Winckel M, Van Biervliet S. Colon transit time in healthy children and adolescents. Int J Colorectal Dis. 2013; 28:1721–1724.

13. Kim ER, Rhee PL. How to interpret a functional or motility test - colon transit study. J Neurogastroenterol Motil. 2012; 18:94–99.

14. Lembo AJ, Ullman SP. Constipation. In : Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran's gastrointestinal and liver disease. 9th ed. Philadelphia: Saunders Elsevier Co.;2010. p. 259–284.

15. de Lorijn F, van Wijk MP, Reitsma JB, van Ginkel R, Taminiau JA, Benninga MA. Prognosis of constipation: clinical factors and colonic transit time. Arch Dis Child. 2004; 89:723–727.

16. Benninga MA, Büller HA, Tytgat GN, Akkermans LM, Bossuyt PM, Taminiau JA. Colonic transit time in constipated children: does pediatric slow-transit constipation exist? J Pediatr Gastroenterol Nutr. 1996; 23:241–251.

17. Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006; 130:1519–1526.

18. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006; 130:1527–1537.

19. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology. 1987; 92:40–47.

20. Papadopoulou A, Clayden GS, Booth IW. The clinical value of solid marker transit studies in childhood constipation and soiling. Eur J Pediatr. 1994; 153:560–564.